- Current report filing (8-K)
03 Février 2009 - 2:39PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) February 2, 2009
HEMAGEN
DIAGNOSTICS, INC.
(Exact
name of Registrant as specified in its Charter)
Delaware
|
|
1-11700
|
|
04-2869857
|
(State
or Other Jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No. )
|
9033
Red Branch Road, Columbia, MD
|
|
|
|
21045
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code
(410)
740-3198
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 5.02 Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
(b)
On
October 28, 2008, Rick Edwards, a director of Registrant, notified it that he
would not seek re-nomination or re-election to the Board of Directors of the
Registrant at the 2009 annual meeting of shareholders. On February 2,
2009, Mr. Edwards notified the Registrant that he was resigning immediately from
the Board as a result of demands from other commitments. Mr. Edwards
was a valued member of the Registrant's Board of Directors and will be missed.
No successor to Mr. Edwards has been appointed at this
time.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be
signed
on its
behalf by the undersigned hereunto duly authorized.
|
HEMAGEN DIAGNOSTICS,
INC.
|
|
|
|
|
|
Date:
February 2, 2009
|
By:
|
/s/William
P. Hales
|
|
|
|
William
P. Hales
|
|
|
|
President
|
|
|
|
|
|
Hemagen Diagnostics (CE) (USOTC:HMGN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Hemagen Diagnostics (CE) (USOTC:HMGN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Hemagen Diagnostics Inc (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur